Flowers Foods Q3 2026 Results: Net Income $14.4 Million on Revenue of $1.17 Billion
- US stocks
- Earnings
- Consumer Staples
Flowers Foods (NYSE: FLO) reported results for its third quarter of 2026, the 12-week period ended 10 Oct 2026. Revenue was $1.17 billion and net income (GAAP) was $14.4 million, and the company said on 12 Nov 2026 that the quarter was a challenging one for the business. Diluted EPS was $0.07 (GAAP), and adjusted diluted EPS, a company-defined measure that excludes certain items, was $0.10.
Key highlights
- Revenue: $1.17 billion, down 4.7% YoY
- Net income (GAAP): $14.4 million, down 63.6% YoY
- Diluted EPS (GAAP): $0.07, down from $0.19 a year earlier
- Adjusted diluted EPS (company-defined): $0.10, down from $0.23
- Adjusted EBITDA (company-defined): $78.9 million, down 33.2% YoY
Summary
| Particulars | Q3 2026 | Q3 2025 | YoY |
|---|---|---|---|
| Revenue | 1,169.1 | 1,226.6 | -4.7% |
| 32.2 | 66.5 | -51.5% | |
| Operating margin | 2.76% | 5.42% | -2.66 pp |
| 14.4 | 39.5 | -63.6% | |
| Net income margin | 1.23% | 3.22% | -1.99 pp |
| Diluted EPS ($) | 0.07 | 0.19 | -63.2% |
Figures are in $ million except EPS; YoY compares with Q3 2025. Q3 2026 is the three months to 10 Oct 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.
The table shows revenue of $1.17 billion in the third quarter, down 4.7% from $1.23 billion a year earlier. Operating income fell 51.5% to $32.2 million, and net income fell 63.6% to $14.4 million, on a GAAP basis.
Net income was 1.2% of revenue this quarter, against 3.2% a year earlier, a decline of 2.0 percentage points. Operating income was 2.8% of revenue, against 5.4% a year earlier. The company's adjusted EBITDA margin was 6.8%, a 280-basis point decrease.
Adjusted figures exclude one-off items
The company's adjusted net income of $21.4 million and adjusted diluted EPS of $0.10 are company-defined measures that exclude items such as restructuring charges, plant closure costs and impairment of assets, restructuring-related implementation costs, and legal settlements. The company reported plant closure costs and impairment of assets of $1.5 million and restructuring charges of $4.6 million in the quarter.
Adjusted EBITDA of $78.9 million is also a company-defined measure. The release reconciles it to net income (GAAP).
Sales volume fell and pricing rose
The company says consolidated pricing/mix increased 2.3% while volume declined 7.0%. Branded Retail net sales decreased 5.1% to $772.1 million, and Other net sales decreased 4.0% to $397.0 million. The company attributes the Other decline partly to lower sales of store branded products and partly to discontinued business.
The company says the pace of improvement for Nature's Own has been slower than anticipated, primarily in loaf.
Outlook lowered for fiscal 2026
The company now expects fiscal 2026 net sales of approximately $5.016 billion to $5.063 billion, compared with prior guidance of $5.070 billion to $5.142 billion. It expects adjusted EBITDA of approximately $415 million to $430 million, against prior guidance of $453 million to $481 million.
The company now expects adjusted diluted EPS of approximately $0.63 to $0.68 per share, compared with prior guidance of $0.75 to $0.85 per share. It expects GAAP net income per diluted share of $0.51 to $0.56 for the full year.
Inference
The company's year-to-date dividends paid were $107.6 million, and its third-quarter dividends paid were $26.6 million. The release does not state a dividend per share or its payment dates, nor a share repurchase authorisation beyond the quarter's small repurchases.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

